Sfoglia per AUTORE
MURPHY SA
Collezione AOU Città della Salute di Torino

  

Items : 4

Rationale and design of the effect of evolocumab in patients at high cardiovascular risk without prior myocardial infarction or stroke (VESALIUS-CV) trial. in American heart journal / Am Heart J. 2024 Mar;269:179-190. doi: 10.1016/j.ahj.2023.12.004. Epub 2023 Dec 29.
2024
AOU Città della Salute di Torino

Wang H; Bhatia AK; Giugliano RP; Elliott-Davey M; Diaz R; Leiter LA; De Ferrari GM; Murphy SA; Ruzza A; Marston NA; Bohula EA; Sabatine MS;

Association Between Achieved Low-Density Lipoprotein Cholesterol Levels and Long-Term Cardiovascular and Safety Outcomes: An Analysis of FOURIER-OLE. in Circulation / Circulation. 2023 Apr 18;147(16):1192-1203. doi: 10.1161/CIRCULATIONAHA.122.063399. Epub 2023 Feb 13
2023
AOU Città della Salute di Torino

Giugliano RP; Wang B; Monsalvo ML; López JAG; Elliott-Davey M; Mach F; Flores-Arredondo JH; Lopez-Miranda J; Schiele F; Gouni-Berthold I; Abbasi S; Toth K; Gaciong ZA; De Ferrari GM; Murphy SA; Im K; Kuder JF; Atar D; Wiviott SD; Park JG; O'Donoghue ML; Gaba P; Sabatine MS;

Effect of Evolocumab on Type and Size of Subsequent Myocardial Infarction: A Prespecified Analysis of the FOURIER Randomized Clinical Trial. in JAMA cardiology / JAMA Cardiol. 2020 Jul 1;5(7):787-793. doi: 10.1001/jamacardio.2020.0764.
2020
AOU Città della Salute di Torino

Wiviott SD; Giugliano RP; Morrow DA; De Ferrari GM; Lewis BS; Huber K; Kuder JF; Murphy SA; Forni DM; Kurtz CE; Honarpour N; Keech AC; Sever PS; Pedersen TR; Sabatine MS;

2020
AOU Città della Salute di Torino

Gencer B; Mach F; Murphy SA; De Ferrari GM; Huber K; Lewis BS; Ferreira J; Kurtz CE; Wang H; Honarpour N; Keech AC; Sever PS; Pedersen TR; Sabatine MS; Giugliano RP;